Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / First Trust NYSE(R) Arca(R) Biotechnology Index Fund
-
Shares outstanding
-
11,300,576
-
Total 13F shares
-
7,663,624
-
Share change
-
+138,707
-
Total reported value
-
$530,343,559
-
Put/Call ratio
-
49%
-
Price per share
-
$69.18
-
Number of holders
-
78
-
Value change
-
+$9,595,710
-
Number of buys
-
2
Institutional Holders of First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund (FBT) as of Q4 2013
As of 31 Dec 2013,
First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund (FBT) was held by
78 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,663,624 shares.
The largest 10 holders included
MORGAN STANLEY, WELLS FARGO & COMPANY/MN, GOLDMAN SACHS GROUP INC, BANK OF AMERICA CORP /DE/, UBS AG, LPL Financial LLC, RAYMOND JAMES & ASSOCIATES, ROYAL BANK OF CANADA, CHURCHILL MANAGEMENT Corp, and McKinley Carter Wealth Services, Inc..
This page lists
78
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.